Naltrexon Vitaflo (Naltrexone Hydrochloride)

Naltrexone Hydrochloride acts as a competitive antagonist at μ, κ, and δ opioid receptors. By occupying these receptors, it blocks the action of both endogenous opioids and external opioid substances, diminishing the rewarding sensations that drive alcohol and opioid use.

The specific dose and dosing schedule of Naltrexon Vitaflo are determined by the prescribing clinician based on the individual’s medical condition, treatment goals, and response to therapy. Patients should follow the prescriber’s instructions exactly.

The safety of Naltrexon Vitaflo in pregnancy and lactation has not been definitively established. Healthcare providers should weigh potential benefits against unknown risks and consider alternative therapies when treating pregnant or nursing individuals.

To request Naltrexon Vitaflo, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Naltrexon Vitaflo contains the same active ingredient, naltrexone hydrochloride, as other branded or generic opioid antagonists. Its clinical profile, including efficacy in reducing cravings and blocking opioid receptors, is comparable, though formulation differences such as tablet size or excipients may vary between products.

Naltrexon Vitaflo should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight, and extreme temperature fluctuations to maintain its stability and potency.

Naltrexon Vitaflo is taken orally, typically as a tablet swallowed with water. The exact timing relative to meals or other medications is determined by the prescriber, who will provide detailed administration instructions.

Serious risks include severe liver injury, worsening depression or emergence of suicidal thoughts, and rare allergic reactions such as anaphylaxis. Patients should be monitored regularly for hepatic function and mental health changes, and any signs of an allergic response require immediate medical attention.

Naltrexon Vitaflo is contraindicated in individuals with acute hepatitis, severe liver disease, or those currently using opioid agonists, as it can precipitate withdrawal. It should also be avoided in patients with known hypersensitivity to naltrexone or any of the tablet’s excipients.